Kyle Gano insider trades

Open-market stock purchases and sales by Kyle Gano, Chief Executive Officer at Neurocrine Biosciences Inc, from SEC Form 4 filings since Sep 4, 2013.

Recent trades

DateStockTradeValue
Sep 11, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Sep 11, 2026NBIX Neurocrine Biosciences IncSold (not open market)$529K
Sep 11, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Sep 11, 2026NBIX Neurocrine Biosciences IncSold (not open market)$155K
Feb 13, 2026NBIX Neurocrine Biosciences IncSold (not open market)$150K
Feb 13, 2026NBIX Neurocrine Biosciences IncSold (not open market)$172K
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncSold (not open market)$668K
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 12, 2026NBIX Neurocrine Biosciences IncSold (not open market)$326K
Feb 12, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Jan 31, 2026NBIX Neurocrine Biosciences IncSold (not open market)$215K
Jan 31, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Jan 16, 2026NBIX Neurocrine Biosciences IncSold$240K
Jan 16, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Jan 16, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Jan 16, 2026NBIX Neurocrine Biosciences IncSold$4.6M
Nov 4, 2025NBIX Neurocrine Biosciences IncSold$42.6K
Nov 1, 2025NBIX Neurocrine Biosciences IncBought (not open market)—

Companies traded

  • NBIX Neurocrine Biosciences Inc: 70 sales, last Sep 11, 2026

Get free alerts when Kyle Gano files a new trade →